- Home
- ELDN vs DOYU Comparison
ELDN vs DOYU Comparison
Compare ELDN & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- DOYU
- Stock Information
- Founded
- ELDN 2004
- DOYU 2014
- Country
- ELDN United States
- DOYU China
- Employees
- ELDN N/A
- DOYU N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- DOYU Computer Software: Programming Data Processing
- Sector
- ELDN Health Care
- DOYU Technology
- Exchange
- ELDN Nasdaq
- DOYU Nasdaq
- Market Cap
- ELDN 178.4M
- DOYU 195.9M
- IPO Year
- ELDN N/A
- DOYU 2019
- Fundamental
- Price
- ELDN $3.67
- DOYU $8.47
- Analyst Decision
- ELDN Strong Buy
- DOYU Hold
- Analyst Count
- ELDN 2
- DOYU 1
- Target Price
- ELDN $12.50
- DOYU $7.00
- AVG Volume (30 Days)
- ELDN 849.2K
- DOYU 60.4K
- Earning Date
- ELDN 08-18-2025
- DOYU 09-11-2025
- Dividend Yield
- ELDN N/A
- DOYU 230.59%
- EPS Growth
- ELDN N/A
- DOYU N/A
- EPS
- ELDN N/A
- DOYU N/A
- Revenue
- ELDN N/A
- DOYU $575,786,186.00
- Revenue This Year
- ELDN N/A
- DOYU N/A
- Revenue Next Year
- ELDN N/A
- DOYU N/A
- P/E Ratio
- ELDN N/A
- DOYU N/A
- Revenue Growth
- ELDN N/A
- DOYU N/A
- 52 Week Low
- ELDN $2.38
- DOYU $5.68
- 52 Week High
- ELDN $5.54
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- ELDN 67.56
- DOYU 70.15
- Support Level
- ELDN $3.64
- DOYU $7.05
- Resistance Level
- ELDN $3.93
- DOYU $8.65
- Average True Range (ATR)
- ELDN 0.23
- DOYU 0.44
- MACD
- ELDN 0.05
- DOYU 0.15
- Stochastic Oscillator
- ELDN 71.91
- DOYU 98.11
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.